These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
315 related articles for article (PubMed ID: 11370817)
1. Reporter gene transgenic mice as a tool for analyzing the molecular mechanisms underlying experimental carcinogenesis. Nishikawa A; Suzuki T; Masumura K; Furukawa F; Miyauchi M; Nakamura H; Son HY; Nohmi T; Hayashi M; Hirose M J Exp Clin Cancer Res; 2001 Mar; 20(1):111-5. PubMed ID: 11370817 [TBL] [Abstract][Full Text] [Related]
2. Organ variation in the mutagenicity of dimethylnitrosamine in Big Blue mice. Suzuki T; Itoh T; Hayashi M; Nishikawa Y; Ikezaki S; Furukawa F; Takahashi M; Sofuni T Environ Mol Mutagen; 1996; 28(4):348-53. PubMed ID: 8991063 [TBL] [Abstract][Full Text] [Related]
3. 1,3-butadiene: cancer, mutations, and adducts. Part II: Roles of two metabolites of 1,3-butadiene in mediating its in vivo genotoxicity. Recio L; Saranko CJ; Steen AM Res Rep Health Eff Inst; 2000 Mar; (92):49-87; discussion 141-9. PubMed ID: 10925839 [TBL] [Abstract][Full Text] [Related]
4. Tissue-specific mutant frequencies and mutational spectra in cyclophosphamide-treated lacI transgenic mice. Gorelick NJ; Andrews JL; deBoer JG; Young R; Gibson DP; Walker VE Environ Mol Mutagen; 1999; 34(2-3):154-66. PubMed ID: 10529740 [TBL] [Abstract][Full Text] [Related]
5. Mutational spectrum of dimethylnitrosamine in the liver of 3- and 6-week-old lacI transgenic mice. de Boer JG; Mirsalis JC; Glickman BW Environ Mol Mutagen; 1999; 34(2-3):80-3. PubMed ID: 10529729 [TBL] [Abstract][Full Text] [Related]
6. The genetic analysis of lacI mutations in sectored plaques from Big Blue transgenic mice. Stuart GR; Gorelick NJ; Andrews JL; de Boer JG; Glickman BW Environ Mol Mutagen; 1996; 28(4):385-92. PubMed ID: 8991067 [TBL] [Abstract][Full Text] [Related]
7. Comparison of mutant frequencies at the transgenic lambda LacI and cII/cI loci in control and ENU-treated Big Blue mice. Zimmer DM; Harbach PR; Mattes WB; Aaron CS Environ Mol Mutagen; 1999; 33(3):249-56. PubMed ID: 10334627 [TBL] [Abstract][Full Text] [Related]
8. In vivo genotoxicity of 2-amino-3,8-dimethylimidazo[4, 5-f]quinoxaline in lacI transgenic (Big Blue) mice. Itoh T; Suzuki T; Nishikawa A; Furukawa F; Takahashi M; Xue W; Sofuni T; Hayashi M Mutat Res; 2000 Jun; 468(1):19-25. PubMed ID: 10863154 [TBL] [Abstract][Full Text] [Related]
9. In vivo mutagenicity and hepatocarcinogenicity of 2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline (MeIQx) in bitransgenic c-myc/lambda lacZ mice. Ryu DY; Pratt VS; Davis CD; Schut HA; Snyderwine EG Cancer Res; 1999 Jun; 59(11):2587-92. PubMed ID: 10363978 [TBL] [Abstract][Full Text] [Related]
10. Mutagenic response to benzene and tris(2,3-dibromopropyl)-phosphate in the lambda lacI transgenic mouse mutation assay: a standardized approach to in vivo mutation analysis. Provost GS; Mirsalis JC; Rogers BJ; Short JM Environ Mol Mutagen; 1996; 28(4):342-7. PubMed ID: 8991062 [TBL] [Abstract][Full Text] [Related]
11. Detection of oxidative DNA damage, cell proliferation and in vivo mutagenicity induced by dicyclanil, a non-genotoxic carcinogen, using gpt delta mice. Umemura T; Kuroiwa Y; Tasaki M; Okamura T; Ishii Y; Kodama Y; Nohmi T; Mitsumori K; Nishikawa A; Hirose M Mutat Res; 2007 Sep; 633(1):46-54. PubMed ID: 17581771 [TBL] [Abstract][Full Text] [Related]
12. A strategy for the application of transgenic rodent mutagenesis assays. Gorelick NJ; Mirsalis JC Environ Mol Mutagen; 1996; 28(4):434-42. PubMed ID: 8991075 [TBL] [Abstract][Full Text] [Related]
13. Differential in vivo mutagenicity of the carcinogen/non-carcinogen pair 2,4- and 2,6-diaminotoluene. Hayward JJ; Shane BS; Tindall KR; Cunningham ML Carcinogenesis; 1995 Oct; 16(10):2429-33. PubMed ID: 7586147 [TBL] [Abstract][Full Text] [Related]
14. Parameters affecting the use of the lac repressor system in eukaryotic cells and transgenic animals. Wyborski DL; DuCoeur LC; Short JM Environ Mol Mutagen; 1996; 28(4):447-58. PubMed ID: 8991077 [TBL] [Abstract][Full Text] [Related]
15. Effects of O (6)-alkylguanine-DNA alkyltransferase deficiency in Escherichia coli as the host for the detection of mutations in lacI transgenic mice. Sui H; Suzuki M; Yamada M; Hara T; Kawakami K; Shibuya T; Nohmi T; Sofuni T Environ Mol Mutagen; 1999; 34(2-3):221-6. PubMed ID: 10529748 [TBL] [Abstract][Full Text] [Related]
16. Assessment of 1,3-butadiene mutagenicity in the bone marrow of B6C3F1 lacI transgenic mice (Big Blue): a review of mutational spectrum and lacI mutant frequency after a 5-day 625 ppm 1,3-butadiene exposure. Recio L; Meyer KG; Pluta LJ; Moss OR; Saranko CJ Environ Mol Mutagen; 1996; 28(4):424-9. PubMed ID: 8991073 [TBL] [Abstract][Full Text] [Related]
17. Transmission of mutations in the lacI transgene to the offspring of ENU-treated Big Blue male mice. Barnett LB; Tyl RW; Shane BS; Shelby MD; Lewis SE Environ Mol Mutagen; 2002; 40(4):251-7. PubMed ID: 12489115 [TBL] [Abstract][Full Text] [Related]
18. A new transgenic mouse mutagenesis test system using Spi- and 6-thioguanine selections. Nohmi T; Katoh M; Suzuki H; Matsui M; Yamada M; Watanabe M; Suzuki M; Horiya N; Ueda O; Shibuya T; Ikeda H; Sofuni T Environ Mol Mutagen; 1996; 28(4):465-70. PubMed ID: 8991079 [TBL] [Abstract][Full Text] [Related]
19. Mutant frequencies and mutation spectra of dimethylnitrosamine (DMN) at the lacI and cII loci in the livers of Big Blue transgenic mice. Shane BS; Smith-Dunn DL; de Boer JG; Glickman BW; Cunningham ML Mutat Res; 2000 Sep; 452(2):197-210. PubMed ID: 11024479 [TBL] [Abstract][Full Text] [Related]
20. Elevated mutant frequencies in gene lacI in splenic lipopolysaccharide blasts after exposure to activated phagocytes in vitro. Felix K; Lin S; Janz S Eur J Immunol; 1997 Sep; 27(9):2160-4. PubMed ID: 9341754 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]